Study on Communication Comprehension in the Schizophrenic Spectrum

NCT03225027 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2019-07-29

No results posted yet for this study

Summary

The purpose of the present study is to evaluate the effect of emotional prosody on the perception of emotional discourse in the schizophrenic spectrum. The investigators hypothesize that participant may use emotional prosody as an emotional cue to understand the emotional content of discourse.

Conditions

  • Schizophrenia Simple

Interventions

BEHAVIORAL

Emotional judgment task

Participants had to indicate on a computer the emotional intensity of audio recordings.

BEHAVIORAL

Post-experimental questionnaire

Participants will be invited to give us the cognitive strategy used to resolve the emotional judgment task.

BEHAVIORAL

Recognition task

Participants will be invited to indicate which recordings they had heard during the emotional judgment task to verify that they have paid attention to the emotional task.

BEHAVIORAL

Detection task

Participants indicate every time they heard a given sound in order to verify their audition level.

OTHER

CAPE-42

This questionnaire allows evaluating the nature of psychotic experiences.

DIAGNOSTIC_TEST

Trait Emotional Intelligence Questionnaire

To evaluate their emotional intelligence.

DIAGNOSTIC_TEST

Positive And Negative Syndrome Scale

Evaluating the clinical status of patients with schizophrenia.

OTHER

Mini International Neuropsychiatric Interview

Evaluating the exclusion criteria in healthy participants.

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Mouna TRABELSI, MD · HDJ François Villon (Centre Hospitaliser René-Dubos)

  • Virginie BEAUCOUSIN, PhD · CRFDP (University of Rouen)

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-15
Primary Completion
2019-05-27
Completion
2019-05-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03225027 on ClinicalTrials.gov